Kemocarb Injection 450mg/45ml

About Kemocarb Injection 450mg/45ml

Kemocarb Injection 450mg/45ml Uses

• Treatment of advanced ovarian cancer as part of combination chemotherapy
• Management of small cell lung cancer in adult patients
• Application in head and neck cancer treatment protocols
• Part of chemotherapy regimens for certain bladder cancers
• A component of pre-transplant conditioning in some cancer treatment plans

Kemocarb Injection 450mg/45ml Benefits

• Support for tumor shrinkage when combined with other chemotherapy drugs
• A well established option in cancer centers across Pakistan
• Fewer kidney related side effects compared to some other platinum drugs
• Effective disease control in several solid tumor types
• A trusted part of standard oncology protocols worldwide

Oncology units in Lahore, Karachi, Islamabad, and Rawalpindi use Kemocarb Injection as part of structured chemotherapy plans for eligible cancer patients.

This injection is given only under the supervision of a qualified oncologist, usually through a hospital or cancer care center.

Regular blood tests are needed during treatment, since this medicine can affect blood cell counts and kidney function over time.

Drug Class

• Platinum based chemotherapy agent
• Cytotoxic antineoplastic drug
• Injectable oncology medicine

Kemocarb Injection 450mg/45ml formula

• Carboplatin

Available forms

• Injection

How to use Kemocarb Injection 450mg/45ml?

• Administration is done only by a trained healthcare professional in a hospital or clinic setting.
• The dose depends on body surface area, kidney function, and the type of cancer being treated.
• A slow intravenous infusion, usually over 15 to 60 minutes, is the standard method of use.
• Pre-treatment blood tests are required to confirm safe kidney and bone marrow function.
• Repeat cycles are scheduled by the treating oncologist, typically every 3 to 4 weeks.

Drug Interactions

Kemocarb Injection can interact with several other medicines, and combinations are usually managed carefully by the treating oncologist.

• Aminoglycoside Antibiotics: Combined use may increase the risk of kidney and hearing related side effects.
• Other Chemotherapy Drugs: Bone marrow suppression risk increases when combined with other cytotoxic agents.
• Live Vaccines: Vaccination with live vaccines is generally avoided during treatment due to a weakened immune response.
• Phenytoin: Blood levels of phenytoin may be reduced during chemotherapy treatment.

Risks and warnings

• Bone Marrow Suppression: This medicine can lower white blood cells, red blood cells, and platelets, raising infection and bleeding risk.
• Kidney Function: Regular kidney function tests are required before and during treatment.
• Pregnancy Risk: This medicine is not recommended during pregnancy due to potential harm to the baby.
• Allergic Reactions: Some patients may develop hypersensitivity reactions, especially with repeated cycles.

Side Effects

Kemocarb Injection can cause a range of side effects, since it works by affecting rapidly dividing cells in the body.

• Nausea and vomiting
• Low blood cell counts, leading to fatigue or easy bruising
• Hair thinning or hair loss
• Loss of appetite
• Tingling or numbness in hands and feet

Serious reactions are less common, but urgent medical care is needed if any of the following develop.

• Signs of severe infection, such as high fever or chills
• Unusual bleeding or bruising
• Severe allergic reaction, including swelling of the face or difficulty breathing
• Signs of kidney problems, such as reduced urination

Storage Conditions

Store this injection in a refrigerator between 2 to 8 degrees Celsius, away from light. Keep unopened vials in their original packaging and dispose of used vials according to hospital safety protocols.